AMBALAL SARABHAI ENTERPRISES Financial Statement Analysis
|
||
|
The Revenues of AMBALAL SARABHAI ENTERPRISES have increased by 13.03% YoY .
The Earnings Per Share (EPS) of AMBALAL SARABHAI ENTERPRISES has increased by 262.50 % YoY. |
||
AMBALAL SARABHAI ENTERPRISES Last 5 Annual Financial Results
[BOM: 500009|NSE : AMBALALSA]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹196 Cr | ₹174 Cr | ₹170 Cr | ₹197 Cr | ₹164 Cr |
| Expenses | ₹188 Cr | ₹165 Cr | ₹161 Cr | ₹172 Cr | ₹165 Cr |
| Operating Profit (Excl OI) | ₹8.61 Cr | ₹8.65 Cr | ₹8.84 Cr | ₹25 Cr | ₹-1.54 Cr |
| Other Income | ₹11 Cr | ₹10 Cr | ₹12 Cr | ₹42 Cr | ₹31 Cr |
| Interest | ₹4.79 Cr | ₹6.09 Cr | ₹2.71 Cr | ₹2.04 Cr | ₹3.20 Cr |
| Depreciation | ₹4.01 Cr | ₹3.58 Cr | ₹2.76 Cr | ₹2.32 Cr | ₹2.41 Cr |
| Profit Before Tax | ₹4.83 Cr | ₹6.65 Cr | ₹15 Cr | ₹54 Cr | ₹33 Cr |
| Profit After Tax | ₹4.93 Cr | ₹5.68 Cr | ₹11 Cr | ₹47 Cr | ₹29 Cr |
| Consolidated Net Profit | ₹4.93 Cr | ₹5.68 Cr | ₹11 Cr | ₹47 Cr | ₹29 Cr |
| Earnings Per Share (Rs) | ₹2.32 | ₹0.64 | ₹0.74 | ₹1.49 | ₹6.16 |
| PAT Margin (%) | 8.54 | 2.44 | 3.16 | 6.53 | 23.39 |
| ROE(%) | 11.94 | 3.57 | 4.25 | 9.13 | 48.74 |
| ROCE(%) | 11.52 | 5.20 | 7.16 | 11.18 | 45.53 |
| Total Debt/Equity(x) | 0.33 | 0.35 | 0.33 | 0.33 | 0.21 |
Key Financials |
||
| Market Cap | : | ₹ 310.6 Cr |
| Revenue (TTM) | : | ₹ 205.5 Cr |
| Net Profit(TTM) | : | ₹ 12.7 Cr |
| EPS (TTM) | : | ₹ 1.7 |
| P/E (TTM) | : | 24.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AMBALAL SARABHAI ENTERPRISES | 4.9% | -7.2% | 34% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.8% | -2.5% | 11.9% |
| DIVIS LABORATORIES | 1.9% | 6.6% | 55.1% |
| TORRENT PHARMACEUTICALS | 0.3% | 2% | 35.9% |
| CIPLA | 0.9% | -0.8% | -10.9% |
| DR REDDYS LABORATORIES | 0.1% | 1.4% | -9.3% |
| MANKIND PHARMA | 1.9% | 3.5% | -7% |
| LUPIN | -1.4% | -4.6% | 2% |
| ZYDUS LIFESCIENCES | 3.5% | 4.7% | 13.8% |
AMBALAL SARABHAI ENTERPRISES Revenues
[BOM: 500009|NSE : AMBALALSA]
| Y-o-Y | 13.03 % |
| 5 Yr CAGR | 4.64 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹196 Cr | 13.03 | |
| Mar2025 | ₹174 Cr | 1.93 | |
| Mar2024 | ₹170 Cr | -13.45 | |
| Mar2023 | ₹197 Cr | 20.23 | |
| Mar2022 | ₹164 Cr | - | |
AMBALAL SARABHAI ENTERPRISES Operating Profit
[BOM: 500009|NSE : AMBALALSA]
| Y-o-Y | -0.52 % |
| 5 Yr CAGR | Positive |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹8.61 Cr | -0.52 | |
| Mar2025 | ₹8.65 Cr | -2.15 | |
| Mar2024 | ₹8.84 Cr | -64.96 | |
| Mar2023 | ₹25 Cr | Positive | |
| Mar2022 | ₹-1.54 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -11.85 % |
| 5 Yr CAGR | Positive |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 4.39% | -11.85 | |
| Mar2025 | 4.98% | -4.05 | |
| Mar2024 | 5.19% | -59.52 | |
| Mar2023 | 12.82% | Positive | |
| Mar2022 | -0.94% | - | |
AMBALAL SARABHAI ENTERPRISES Profit After Tax
[BOM: 500009|NSE : AMBALALSA]
| Y-o-Y | -13.20 % |
| 5 Yr CAGR | -35.98 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.93 Cr | -13.20 | |
| Mar2025 | ₹5.68 Cr | -50.37 | |
| Mar2024 | ₹11 Cr | -75.76 | |
| Mar2023 | ₹47 Cr | 60.86 | |
| Mar2022 | ₹29 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 250.00 % |
| 5 Yr CAGR | -22.27 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 8.54 % | 250.00 | |
| Mar2025 | 2.44 % | -22.78 | |
| Mar2024 | 3.16 % | -51.61 | |
| Mar2023 | 6.53 % | -72.08 | |
| Mar2022 | 23.39 % | - | |
AMBALAL SARABHAI ENTERPRISES Earnings Per Share (EPS)
[BOM: 500009|NSE : AMBALALSA]
| Y-o-Y | 262.50 % |
| 5 Yr CAGR | -21.66 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹2.32 | 262.50 | |
| Mar2025 | ₹0.64 | -13.51 | |
| Mar2024 | ₹0.74 | -50.34 | |
| Mar2023 | ₹1.49 | -75.81 | |
| Mar2022 | ₹6.16 | - | |
AMBALAL SARABHAI ENTERPRISES Return on Capital Employed (ROCE)
[BOM: 500009|NSE : AMBALALSA]
| Y-o-Y | 121.54 % |
| 5 Yr CAGR | -29.08 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 11.52% | 121.54 | |
| Mar2025 | 5.2% | -27.37 | |
| Mar2024 | 7.16% | -35.96 | |
| Mar2023 | 11.18% | -75.44 | |
| Mar2022 | 45.53% | - | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Current Share Price | : | ₹40.6 |
| Current MarketCap | : | ₹ 310.6 Cr |
| Updated EOD on | : | Sep 25,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 4.9% |
-7.2% |
34% |
| SENSEX | -0.5% |
-4.8% |
-11% |
AMBALAL SARABHAI ENTERPRISES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | 0.3% | 1.4% | 14.3% |
No NSE index found
You may also like the below Video Courses
FAQ about AMBALAL SARABHAI ENTERPRISES Financials
How the annual revenues of AMBALAL SARABHAI ENTERPRISES have changed ?
The Revenues of AMBALAL SARABHAI ENTERPRISES have increased by 13.03% YoY .
How the Earnings per Share (EPS) of AMBALAL SARABHAI ENTERPRISES have changed?
The Earnings Per Share (EPS) of AMBALAL SARABHAI ENTERPRISES has increased by 262.50 % YoY .
Check out Intrinsic Value of Peers of AMBALAL SARABHAI ENTERPRISES
Compare Stock Analytics of Peers of AMBALAL SARABHAI ENTERPRISES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
